Submitted by Anonymous (not verified) on 15 April 2024 - 14:03
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 5, Status: Authorised